Corbion Unveils BRIGHT 2030 Strategic Plan Following Successful Growth Cycle
Corbion has released its 2025 annual report, marking the end of its Advance 2025 strategic cycle and the transition into a new phase, BRIGHT 2030. The company outlines a trajectory based on strengthening its business portfolio aligned with global market trends, particularly in terms of sustainability.
During the past strategic period, Corbion deepened its business focus around four key areas: natural food preservation, algae-derived ingredients, lactic acid and its derivatives, and natural polymers. These targeted investments enabled the group to capture opportunities related to consumer health, climate change, biodiversity, and the circular economy. Throughout this strategic cycle, Corbion aligned its efforts with the United Nations Sustainable Development Goals, embedding its solutions within global sustainability priorities.
Entering the BRIGHT 2030 Cycle
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Corbion now enters its BRIGHT 2030 strategic cycle on a strengthened foundation and with a clear orientation for future growth. The 2025 annual report provides a comprehensive overview of the financial performance, operations, environmental impact, and strategic direction of the group for the entire year 2025, aimed at shareholders, investors, regulators, and other stakeholders.
In line with earlier guidance, Corbion experienced negative growth in both sales and earnings versus Q1 2025.
Corbion a connu une baisse des ventes et des bénéfices par rapport à l'année précédente.
Risks mentioned
Macroeconomic and geopolitical uncertainty create price and supply-chain challenges.
Negative growth in sales and earnings.
High comparable from Q1 2025 impacting results.
Opportunities identified
Sales in Health & Nutrition expected to strengthen from Q2 onwards.
Cost reduction program to deliver savings as of Q2.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
